Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical CarcinomaNCT03108495IOVAPhase 2Terminated2025-08-22Actual
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple MyelomaNCT03110562KPTIPhase 3Completed2020-02-18Actual
12-Week Open-Label Extension Study of TNX-102 SL in PTSD PatientsNCT03110575Tonix Pharmaceuticals, Inc.Phase 3Terminated2018-07-27Actual
A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804NCT03118570RAREPhase 2Completed2019-10-01Actual
Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaNCT03121586ACADPhase 3Terminated2024-04-30Actual
AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)NCT03127514AMLXPhase 2Completed2019-09-25Actual
The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic CystitisNCT03129126Lipella Pharmaceuticals, Inc.Phase 2Completed2023-08-21Actual
SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.NCT03131154ALDXPhase 3Completed2019-04-19Actual
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye SyndromeNCT03162783ALDXPhase 2Completed2017-07-06Actual
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224APLMPhase 2Recruiting2026-03-30Estimated
Long-Term Outcomes of Ataluren in Duchenne Muscular DystrophyNCT03179631PTC TherapeuticsPhase 3Completed2022-03-05Actual
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)NCT03180684Inovio PharmaceuticalsPhase 2Completed2020-07-23Actual
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisNCT03183245HUMAPhase 3Completed2024-04-22Actual
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)NCT03185013Inovio PharmaceuticalsPhase 3Completed2020-07-08Actual
Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel DiseaseNCT03201445LKFTPhase 2Terminated2020-11-20Actual
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831NCT03201757Alkermes, Inc.Phase 3Completed2023-09-06Actual
Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic SyndromeNCT03205995Omeros CorporationPhase 3Terminated2021-02-02Actual
Addressing Dementia Via Agitation-Centered EvaluationNCT03226522AXSMPhase 2, Phase 3Completed2020-04-17Actual
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsNCT03228667IBRXPhase 2Active not recruiting2029-08-31Estimated
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAXNCT03232567ALTPhase 2Completed2018-03-07Actual
A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)NCT03246529BLRXPhase 3Active not recruiting2020-12-22Actual
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCNCT03257033RenovoRxPhase 3Recruiting2027-06Estimated
Study of SPR001 in Adults With Classic Congenital Adrenal HyperplasiaNCT03257462Spruce BiosciencesPhase 2Completed2019-03-02Actual
Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion BurdenNCT03263091Kyntra BioPhase 3Terminated2023-03-09Actual
p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246NCT03268382Aprea TherapeuticsPhase 2Completed2019-07-10Actual
A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney DiseaseNCT03270956ProkidneyPhase 2Completed2022-11-17Actual
Safety and Efficacy of Repeated Administrations of NurOwn® in ALS PatientsNCT03280056Brainstorm-Cell TherapeuticsPhase 3Completed2020-09-29Actual
ONC201 in Adults With Recurrent H3 K27M-mutant GliomaNCT03295396Jazz PharmaceuticalsPhase 2Terminated2022-12-31Actual
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza ANCT03315104Emergent BioSolutionsPhase 2Completed2019-06-17Actual
Long-Term Safety Study of TafenoquineNCT0332017460 Degrees Pharmaceuticals LLCPhase 2Completed2021-07-13Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.